BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomas
Abstract Background MYC-driven lymphomas are a subset of B-cell lymphomas characterized by genetic alterations that dysregulate the expression of the MYC oncogene. When overexpressed, typically through chromosomal translocations, amplifications, or other mechanisms, MYC can drive uncontrolled cell g...
Saved in:
| Main Authors: | Loris Delrieu, Sieme Hamaidia, Emilie Montaut, Andrea Cecilia Garcia-Sandoval, Camille Teste, Patricia Betton-Fraisse, Thierry Bonnefoix, Sylvain Carras, Rémy Gressin, Christine Lefebvre, Jérôme Govin, Anouk Emadali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Clinical Epigenetics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13148-024-01788-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting MYC: Multidimensional regulation and therapeutic strategies in oncology
by: Yingying Duan, et al.
Published: (2025-07-01) -
Modified screening of MYC promotor region elements using the CRISPR library in ovarian cancer
by: Akiko Yamamoto, et al.
Published: (2025-04-01) -
MYC alterations in multiple myeloma: Genetic insights and prognostic impact
by: Sara Cristóbal-Vargas, et al.
Published: (2025-08-01) -
A Minireview on BET Inhibitors: Beyond Bromodomain Targeting
by: Mikhail S. Iudin, et al.
Published: (2025-03-01) -
The betA/B genes as a key factor in Cronobacter sakazakii survival under desiccation stress
by: Y. Yang, et al.
Published: (2025-08-01)